Alignment Healthcare, Inc. (ALHC) Presents at Morgan Stanley

Core Insights - The company has experienced above-average growth in 2023, continuing the trend from the previous year, attributed to favorable unit economics and strategic positioning within the industry [1] Industry Dynamics - The company anticipates a competitive advantage due to changes in the Stars program, which is expected to enhance its market position [1] - The upcoming V28 phase-in in 2024 is seen as a pivotal moment that will further benefit the company's growth trajectory [1]